Busulfan versus treosulfan conditioning for acute myeloid leukemia and myelodysplastic syndrome: A systematic review and meta-analysis.

MLA

Rehman, Mohammad Ebad Ur, et al. “Busulfan versus Treosulfan Conditioning for Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Systematic Review and Meta-Analysis.” Journal of Clinical Oncology, vol. 41, June 2023, p. e19032. EBSCOhost, https://doi.org/10.1200/JCO.2023.41.16_suppl.e19032.

APA

Rehman, M. E. U., Khan suheb, M., Umar, H., Farheen Naaz, F., Shah, Z., Khan, Z., Cheema, H. A., Basit, J., Fazal, F., Maqbool, S., Farhan, M., Dhama, K., Akbar, U. A., Iftikhar, R., Iftikhar, A., & Anwer, F. (2023). Busulfan versus treosulfan conditioning for acute myeloid leukemia and myelodysplastic syndrome: A systematic review and meta-analysis. Journal of Clinical Oncology, 41, e19032. https://doi.org/10.1200/JCO.2023.41.16_suppl.e19032

Chicago

Rehman, Mohammad Ebad Ur, Mahammed Khan suheb, Haddaya Umar, Fnu Farheen Naaz, Zunairah Shah, Zarak Khan, Huzaifa Ahmad Cheema, et al. 2023. “Busulfan versus Treosulfan Conditioning for Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Systematic Review and Meta-Analysis.” Journal of Clinical Oncology 41 (June): e19032. doi:10.1200/JCO.2023.41.16_suppl.e19032.